The Inner Circle acknowledges, Shana Traina, PhD as a Pinnacle Professional Member
Dr.
With a Bachelor of Arts in Psychology from Humboldt State University, a Master of Arts in Behavioral and Clinical Psychology from Pepperdine University, and a Doctor of Philosophy in Health Services Research from UCLA,
As a certified Dare to Lead facilitator and Executive Leadership Certification recipient from the London School of Economics and Political Science, Dr. Traina is dedicated to guiding teams of researchers toward strategic thinking and the application of scientific practices within business contexts.
Throughout her illustrious 18-year career, Dr. Traina has held pivotal roles at renowned organizations such as Johnson & Johnson and Amgen. Her contributions as a global market access leader and global patient-reported outcomes leader have been instrumental in shaping innovative approaches to health care.
Dr. Traina's commitment to excellence extends beyond her professional endeavors. She actively participates in industry-leading associations such as the Society of Behavioral Medicine and the Dare to Lead Network, where she collaborates with fellow leaders to drive positive change in health behavior science.
Recognized as an invited speaker on women in leadership across various STEM fields, Dr. Traina continues to inspire and empower future generations of leaders. Her dedication to incorporating patient perspectives into health care innovation has earned her accolades, including an invitation to speak before the U.S. Food and Drug Administration.
Looking ahead, Dr. Traina remains steadfast in her mission to advance further in the realm of leadership, nurturing individual talents for greater organizational success and fostering an environment where excellence thrives.
Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-shana-traina-phd-as-a-pinnacle-professional-member-302235349.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
- GameChange Energy completes commissioning of its Genius Tracker™ for Dannevirke Solar Farm in New Zealand
- California American Water Supports Cal Fire Response to Timber Fire
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share